טוען...
Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment
BACKGROUND: Despite its recognised toxicity, antimonial therapy continues to be the first-line drug for cutaneous leishmaniasis (CL) treatment. Intralesional administration of meglumine antimoniate (MA) represents an alternative that could reduce the systemic absorption of the drug and its side effe...
שמור ב:
| הוצא לאור ב: | Mem Inst Oswaldo Cruz |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Instituto Oswaldo Cruz, Ministério da Saúde
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5722261/ https://ncbi.nlm.nih.gov/pubmed/29236929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/0074-027601700125 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|